Oesophageal capsule assessment of gastroesophageal reflux disease in chronic lung disease patients awaiting lung transplant and lung transplant recipients.

Not Applicable

• Conditions: gastroesophageal reflux disease specifically in the chronic lung disease patients awaiting lung transplant and lung transplant recipient population; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12611000271909
• Lead Sponsor: GIVEN Imaging Australia (supply of video capsules)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-03-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients awaiting lung transplantation or recipients of lung transplantation.

Exclusion Criteria

Have difficulty swallowing or have a known oesophageal diverticulum or stricture.
Are pregnant or are planning pregnancy in next 6 weeks.
Are under 18 years of age.
Are unable to give valid informed consent.
Have a cardiac pacemakers or defibrillator.
Have suffered previous episodes of bowel obstruction: other than non-mechanical obstruction in patients with cystic fibrosis.
Plan to have a MRI (magnetic resonance imaging) scan of any part of the body in the next 8 weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified